Back to search
FDAFDA · Food and drugs·Recall number D-0351-2021

PremierZen Black 5000 capsules, 1 capsule per card/24 capsules per box, Distributed by New Premier Group Los Angeles CA 90006 UPC 7 2817542189 4

Published May 5, 2021 · Recall initiated: March 25, 2021

Summary

FDA records drug Class II recall D-0351-2021, published May 5, 2021 and initiated March 25, 2021. Recalling firm: Namoo Enterprise LLC; Status: Terminated; Reported quantity: N/A; Lot: All lots within expiry. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and sildenafil.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Namoo Enterprise LLC
Distributor
Nationwide within the United States
Lot
All lots within expiry
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was PremierZen Black 5000 capsules, 1 capsule per card/24 capsules per box, Distributed by New Premier Group Los Angeles CA 90006 UPC 7 2817542189 4 recalled?

Yes. FDA published recall D-0351-2021 on May 5, 2021. Reported hazard: Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of tadalafil and sildenafil.

What should I do if I have this product?

Voluntary: Firm initiated · Letter